Based on 2 analysts giving stock ratings to Rockwell Medical Inc in the past month.
In the current month, RMTI has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RMTI average Analyst price target in the last month is 20.000.
Based on analysts' estimates, RMTI EPS is projected to reach -0.165 in FY2026Q3, following reported EPS of -0.335 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.34, while Rockwell Medical IncRMTI's earnings per share (EPS) for the previous quarter was USD -0.41. EPS for the next quarter is expected at USD -0.17.